Egypt healthcare market: size, growth and outlook 2026–2032

The largest population in the region moving to universal insurance; a sourcing and manufacturing base for the GCC. Published estimates normalised to 2025 range from USD 14.1 bn to USD 18.3 bn; the Consulting Wallah central estimate is USD 15.5 bn, growing at about 9% a year to USD 28.3 bn by 2032. Scope differences between publishers explain most of the spread — the comparison table below states each one.

Growth is driven by universal Health Insurance System rollout (six phases to ~2030-2032), with private providers supplying ~31% of the Phase 1 network and 30-40% of Phase 2 beds; law No. 87 of 2024 allowing private firms to operate public hospitals for 3-15 years; national Health Strategy 2030 (launched 2024) emphasising access, prevention and advanced facilities.

Context that matters for buyers and suppliers: Egypt total health spending est. USD 14.1 bn in 2025 (EIU), rising to USD 20.2 bn by 2029. Private sector accounts for 65% of health spend, ~90% of it out-of-pocket. 142,000 hospital beds nationwide in 2024; MoHP runs ~1,300 hospitals with ~60% of beds. UHI Phase 1 (Port Said, Luxor, Ismailia, Suez, South Sinai, Aswan) enrolled 5.2 m people by Nov 2025; average registration 81.7%.

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 14.1 bn–USD 18.3 bn; differences are mostly scope.

Included: public and private hospital, clinic, diagnostic and long-term care services and the associated health expenditure. Excluded: pharmaceutical and device product sales, insurance premiums and health IT (covered in separate reports). Published totals differ mainly by whether products and insurance are folded in.

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

• Egypt total health spending est. USD 14.1 bn in 2025 (EIU), rising to USD 20.2 bn by 2029 (GTAI / EIU)
• Private sector accounts for 65% of health spend, ~90% of it out-of-pocket (GTAI / EIU)
• 142,000 hospital beds nationwide in 2024; MoHP runs ~1,300 hospitals with ~60% of beds (GTAI)
• UHI Phase 1 (Port Said, Luxor, Ismailia, Suez, South Sinai, Aswan) enrolled 5.2 m people by Nov 2025; average registration 81.7% (EnterpriseAM)
• UHI contributions: employers 4% of gross wages, employees 1-5%, pensioners 2%; ~30% of population state-subsidised (GTAI; EnterpriseAM)
• Cleopatra Hospitals Group: 6 hospitals, 780 operating beds, 9M2025 revenue EGP 5.32 bn (+39% YoY), EBITDA margin 31.9% (Cleopatra 9M2025 factsheet)
• Egypt pharma market EGP 422 bn (~USD 8.5 bn) in 2025, +37% YoY; ~91% locally produced; >10,000 products (EDA via Zawya)
• UHI Phase 2 target: 12-13 m additional beneficiaries, 69 hospitals, 669 primary-care units; private providers to supply 30-40% of beds (EnterpriseAM)
• Egypt private medical insurance premiums exceed EGP 13 bn (EHA chair) (Amwal Al Ghad)

Where the GCC and India sit

• Egypt total hospital beds: 142,000 (2024) — GTAI
• Egypt hospitals (public + private): 1,798 (2024) — Insights10
• Additional beds needed by 2030: 170,000+ (GAFI); 38,000-120,000 (Colliers) (2030) — GTAI
• UHI Phase 1 enrolment (6 governorates): 5.2 million (2025-11) — EnterpriseAM
• Private health-sector companies: 8,055 (2024) — AmCham Egypt via GTAI
• Egypt pharma exports: ~USD 1.3 bn (target USD 3 bn by 2030) (2025) — EDA via Zawya

Consulting Wallah works this market from both sides: hospital groups in the UAE, Saudi Arabia, India and Bangladesh as buyers, and manufacturers in India, China, Singapore, Malaysia and the US as suppliers through the Network. Our observation is that registration status, in-country stock and structured quotations decide access in the GCC, while price and distributor reach decide it in India. CW observation

Opportunities we see: bed gap of 38,000-170,000+ beds by 2030 (Colliers / GAFI estimates); pPP operation of public hospitals under Law 87/2024; uHI Phase 2 (Minya, Matrouh, Damietta, Kafr El Sheikh, North Sinai) adding 12-13 million beneficiaries, 69 hospitals, 669 PHC units.

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

• Operators and investors: capacity, payer rules and licensing timelines decide returns; design central procurement and insurer contracting into the operating model before opening.
• Suppliers: registration, a local partner and payer-formulary presence are the gates; central tenders reward structured quotations and reliable supply over the lowest price.
• Hospital leaders: payer pressure makes the 25–35% of cost in supplies the margin lever — see the free executive assessment.

1. GTAI (Germany Trade & Invest), Reformen verändern Ägyptens Gesundheitssektor — gtai.de
2. EnterpriseAM, Egypt prepares to double universal health insurance reach before Phase 1 results are in — enterpriseam.com
3. Insights10, Egypt Hospital Market Analysis — insights10.com
4. MarkNtel Advisors, Egypt Healthcare Market Research Report: Forecast (2025-2030) — marknteladvisors.com
5. IMARC Group, Egypt Pharmaceutical Market Size, Share, Trends and Forecast 2026-2034 — imarcgroup.com
6. Zawya / Arab Finance, Egypt's pharma market hits $8.4bln in 2025, ranks 26th globally — zawya.com
7. IFC, The UHC Opportunity for Private Healthcare Providers in Egypt — ifc.org
8. Cleopatra Hospitals Group, Cleopatra Hospitals Group 9M2025 Investor Factsheet — cleopatrahospitals.com
9. Arab Finance, Cleopatra Hospital projects H1 2026 revenue to rise 27% — arabfinance.com
10. Daily News Egypt, Al-Sisi orders acceleration of health insurance rollout, supports private investment — dailynewsegypt.com
11. Economist Intelligence Unit (via GTAI) (2025-08) — USD 14.1 bn (2025) to USD 20.2 bn (2029), CAGR —; scope: country; total health expenditure Egypt (2024: USD 13.5 bn; 2026: 15.7; 2027: 17.1; 2028: 18.2; 2029: 20.2) — source
12. Insights10 (2024-07) — USD 15.40 bn (2023) to USD 28.33 bn (2030), CAGR 9.1%; scope: country; Egypt hospital market (public + private hospitals) — source
13. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
14. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.